Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that
Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that
Peripheral Blood Mononuclear Cells (PBMCs) derived from Leukopaks are a rich source of leukocytes, the ideal starting material for isolating T cells, B cells, natural killer cells, and monocytes. Many
Copyright ©
AllCells. All rights reserved.
